Entire Transcript in Adobe Acrobat Format - National Reference ...

229
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
trying to distinguish as I have understood what we were
about here is whether or not you would agree to be in a
consent protect that would expose you to greater than
minimal risk and that has to be explained with the kind of
things that could happen and make it concrete but would not
be designed to benefit you at all.
And that is the determination that is so
crucial here because that kind of research is done by
researchers and it should only be done when the person has
said, as the researcher is saying, I value scientific
knowledge enough to go through a process with no prospect
of being benefitted by it as opposed to with the lure of
some potential therapeutic payoff for me. And that is why
we distinguished it. We do allow a surrogate in the
potentially therapeutic because we say there the fact that
you have not gone through this process and have not made
that determination ought not to be a total barrier to your
getting that benefit of the innovative treatment or
whatever is being done here.
But where that is not a prospect what is the
justification for using the person? It is just pure use of
a person who has not been given the opportunity to say yea
or nay to that. Not everybody can be presumed to be
willing to go through pain and suffering in order to